Practice Patterns in Cervical Cancer Screening and Human Papillomavirus Testing

被引：13

作者：

Tatsas, Amanda D. ^{[1
]}

Phelan, Darcy F. ^{[2
]}

Gravitt, Patti E. ^{[2
,3
]}

Boitnott, John K. ^{[1
]}

Clark, Douglas P. ^{[1
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA

[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA

[3] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA

来源：

AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2012年 / 138卷 / 02期

关键词：

Human papillomavirus; HPV; Papanicolaou test; Cotesting; 2006 CONSENSUS GUIDELINES; MANAGEMENT; WOMEN; DNA; EXPERIENCE; CYTOLOGY; PROGRAM;

D O I：

10.1309/AJCPPVX91HQMNYZZ

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

The use of human papillomavirus DNA testing plus Papanicolaou (Pap) testing (cotesting) for cervical cancer screening in women 30 years and older has been recommended since 2006. However, few studies have detailed the adoption of such cotesting in clinical practice. We examined the trends in monthly percentage of Pap tests ordered as cotests in our laboratory over a 2.5-year period and used joinpoint regression to identify periods in which there was a change in the average monthly proportion of cotests. Cotesting of patients 30 years and older increased from 15.9% in January 2008 to 39.4% in June 2010. In patients aged 18 to 29 years, cotesting initially increased, but showed a downward trend in the last 14 months of the study, ending at 7.7% in June 2010. Our study highlights increased adoption of age-appropriate cotesting as well as the persistence of age-inappropriate cotesting.

引用

页码：223 / 229

页数：7

共 24 条

[1]

[Anonymous], 2009, Obstet Gynecol, V114, P1409, DOI 10.1097/AOG.0b013e3181c6f8a4

[2]

Austin RM, 2010, ARCH PATHOL LAB MED, V134, P744, DOI 10.1043/1543-2165-134.5.744

[3] Five-Year Experience of Human Papillomavirus DNA and Papanicolaou Test Cotesting [J].

Castle, Philip E. ;

Fetterman, Barbara ;

Poitras, Nanty ;

Lorey, Yhomas ;

Shaber, Ruth ;

Kinney, Walter .

OBSTETRICS AND GYNECOLOGY, 2009, 113 (03) :595-600

[4] The 2006 Consensus Guidelines for the Management of Women With Abnormal Cervical Screening Tests Challenges Remain [J].

Colgan, Terence J. .

CANCER CYTOPATHOLOGY, 2010, 118 (05) :233-237

[5]

Davis DA, 1997, CAN MED ASSOC J, V157, P408

[6] A decade of direct-to-consumer advertising of prescription drugs [J].

Donohue, Julie M. ;

Cevasco, Marisa ;

Rosenthal, Meredith B. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (07) :673-681

[7] Prevalence of HPV infection among females in the United States [J].

Dunne, Eileen F. ;

Unger, Elizabeth R. ;

Sternberg, Maya ;

McQuillan, Geraldine ;

Swan, David C. ;

Patel, Sonya S. ;

Markowitz, Lauri E. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (08) :813-819

[8] Primary care physicians' awareness and adherence to cervical cancer screening guidelines in Texas [J].

Holland-Barkis, P ;

Forjuoh, SN ;

Couchman, GR ;

Capen, C ;

Rascoe, TG ;

Reis, MD .

PREVENTIVE MEDICINE, 2006, 42 (02) :140-145

[9] Low-Risk Human Papillomavirus Testing and Other Nonrecommended Human Papillomavirus Testing Practices Among US Health Care Providers [J].

Lee, Jennifer Wai-Yin ;

Berkowitz, Zahava ;

Saraiya, Mona .

OBSTETRICS AND GYNECOLOGY, 2011, 118 (01) :4-13

[10] Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer [J].

Mayrand, Marie-Helene ;

Duarte-Franco, Eliane ;

Rodrigues, Isabel ;

Walter, Stephen D. ;

Hanley, James ;

Ferenczy, Alex ;

Ratnam, Sam ;

Coutle, Francois ;

Franco, Eduardo L. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (16) :1579-1588

← 1 2 3 →